InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Explore the detailed record of transactions filed by Behrenbruch Christian, 首席执行官. Director active across 1 company, notably Telix Pharmaceuticals Ltd. Aggregated, 1 disclosures have been recorded. Breakdown: 1 buy · 0 sell. Total volume traded: €426k. Activity tracked since 28 April 2026. The latest transaction was disclosed on 28 April 2026 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 条申报中的 1 条
Christian Behrenbruch is the MD & Group CEO at Telix Pharmaceuticals Ltd. He leads the company's operations and development strategies, ensuring its growth and profitability. His experience in the pharmaceutical sector enables him to navigate effectively in a complex environment.